EUVIMEDEUVIMED entdecken
Open Access

Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury

René M Roy iD, Ayed Allawzi iD, Nana Burns, Christina Sul iD, Victoria Rubio, Jessica Graham iD, Kurt Stenmark iD, Eva S Nozik iD, Rubin M Tuder iD, Christine U Vohwinkel iD

The FASEB Journal · 2023-12 · 37 (12)

DOI: 10.1096/fj.202301722r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 20.11.2023. Verfasst von René M Roy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital Colorado, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Acute Lung Injury. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NICHD NIH HHS, Society of Critical Care Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alveolar inflammation is a hallmark of acute lung injury (ALI), and its clinical correlate is acute respiratory distress syndrome—and it is as a result of interactions between alveolar type II cells (ATII) and alveolar macrophages (AM). In the setting of acute injury, the microenvironment of the intra‐alveolar space is determined in part by metabolites and cytokines and is known to shape the AM phenotype. In response to ALI, increased glycolysis is observed in AT II cells, mediated by the transcription factor hypoxia‐inducible factor (HIF) 1α, which has been shown to decrease inflammation. We hypothesized that in acute lung injury, lactate, the end product of glycolysis, produced by ATII cells shifts AMs toward an anti‐inflammatory phenotype, thus mitigating ALI. We found that local intratracheal delivery of lactate improved ALI in two different mouse models. Lactate shifted cytokine expression of murine AMs toward increased IL‐10, while decreasing IL‐1 and IL‐6 expression. Mice with ATII‐specific deletion of Hif1a and mice treated with an inhibitor of lactate dehydrogenase displayed exacerbated ALI and increased inflammation with decreased levels of lactate in the bronchoalveolar lavage fluid; however, all those parameters improved with intratracheal lactate. When exposed to LPS (to recapitulate an inflammatory stimulus as it occurs in ALI), human primary AMs co‐cultured with alveolar epithelial cells had reduced inflammatory responses. Taken together, these studies reveal an innate protective pathway, in which lactate produced by ATII cells shifts AMs toward an anti‐inflammatory phenotype and dampens excessive inflammation in ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophages, AlveolarAcute Lung InjuryMiceHumansAnimalsAlveolar Epithelial CellsLactic AcidInflammationCytokinesAnti-Inflammatory AgentsLipopolysaccharidesLung

Stichwörter der Autor:innen

acute lung injuryacute respiratory distress syndromealveolar epitheliumalveolar macrophageglycolysishypoxia-inducible factorlactate

Substanzen

Lactic AcidCytokinesAnti-Inflammatory AgentsLipopolysaccharides

Autor:innen und Institutionen

  • Children's Hospital Colorado, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Division of Pediatric Critical Care, Department of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Developmental Lung Biology, Cardiovascular Pulmonary Research Laboratories, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Division of Pulmonary Sciences and Critical Care Medicine, Program in Translational Lung Research, University of Colorado School of Medicine, Aurora, Colorado, USA.

ORCID-Profile: René M Roy, Ayed Allawzi, Christina Sul, Jessica Graham, Kurt Stenmark, Eva S Nozik, Rubin M Tuder, Christine U Vohwinkel

Förderung

  • NHLBI NIH HHS
  • NICHD NIH HHS
  • Society of Critical Care Medicine

Zitieren

APA

Roy, R. M., Allawzi, A., Burns, N., Sul, C., Rubio, V., Graham, J., Stenmark, K., Nozik, E. S., Tuder, R. M., & Vohwinkel, C. U. (2023). Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury. The FASEB Journal, 37(12). https://doi.org/10.1096/fj.202301722r

Vancouver

Roy RM, Allawzi A, Burns N, Sul C, Rubio V, Graham J, et al. Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury. The FASEB Journal. 2023;37(12). doi:10.1096/fj.202301722r

BibTeX
@article{Roy2023,
  author = {Roy, René M and Allawzi, Ayed and Burns, Nana and Sul, Christina and Rubio, Victoria and Graham, Jessica and Stenmark, Kurt and Nozik, Eva S and Tuder, Rubin M and Vohwinkel, Christine U},
  title = {Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury},
  journal = {The FASEB Journal},
  year = {2023},
  volume = {37},
  number = {12},
  doi = {10.1096/fj.202301722r}
}
Kostenlos starten →